719 Phase 1 study of the porcupine (PORCN) inhibitor RXC004 in combination with the PD-1 inhibitor nivolumab in patients with advanced solid tumorsNatalie Cook, Ruth Plummer, Aglaia Skolariki et al.|Regular and Young Investigator Award Abstracts|2022Cited by 2